Orbimed Advisors LLC Atri Cure, Inc. Transaction History

Orbimed Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$53.79 - $66.98 $66.1 Million - $82.3 Million	-1,228,189 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$31.78 - $51.19 $9.53 Million - $15.4 Million	300,000 Added 32.32%	1,228,189 $55.2 Million
Q1 2020 May 15, 2020	BUY	$24.49 - $43.84 $18.6 Million - $33.3 Million	759,568 Added 450.46%	928,189 $31.2 Million
Q4 2019 Feb 14, 2020	BUY	$24.06 - $32.51 $4.06 Million - $5.48 Million	168,621 New	168,621 $5.48 Million

229

47.1M

25.8K

4.5K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.78B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.